v3.26.1
Condensed Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
License and collaborations revenue $ 2,157 $ 4,370
Operating expenses:    
Research and development 10,577 7,953
General and administrative 5,944 6,346
Total operating expenses 16,521 14,299
Loss from operations (14,364) (9,929)
Fair value change in warrant liabilities (51,364) 2,805
Financing costs (582) (1,372)
Interest expense (69) 0
Other income, net 844 302
Loss before income taxes (65,535) (8,194)
Benefit (provision) for income taxes 0 0
Net loss (65,535) (8,194)
Other comprehensive loss, net of tax 0 0
Comprehensive loss $ (65,535) $ (8,194)
Net loss per share:    
Basic (in dollars per share) $ (0.75) $ (0.24)
Diluted (in dollars per share) $ (0.75) $ (0.24)
Number of shares used in per share calculations:    
Basic weighted average shares outstanding (in shares) 86,891,352 33,884,920
Diluted weighted average shares outstanding (in shares) 86,891,352 33,884,920

Source